<prompt> Apixaban is a new drug that acts byInhibiting TNF alphaInhibiting coagulation factor XaInhibiting platelet aggregationActivating plasminogen  <response>: Rivaroxaban and Apixaban are newer oral anticoagulants that act by inhibiting factor Xa. Newer oral anticoagulants that are currently being asked in the exams are: Direct thrombin inhibitor- Dabigatran Direct factor Xa inhibitors Apixaban Rivaroxaban Edoxaban Betrixaban 